MSTN and neoplasm: Several molecular signaling pathways within the myocyte have been implicated in driving tumor-induced muscle wasting, including forkhead boxO (FoxO), signal transducer and activator of transcription 3 (STAT3), and myostatin-activin receptor 2B [30].